TRAX financials
First Tracks Biotherapeutics (TRAX) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
TRAX income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $0.00 | -$139.61M | -$179.01M | -$166.09M | 0.00 |
| 2024 | $0.00 | -$152.34M | -$181.10M | -$163.71M | 0.00 |
| 2023 | $0.00 | $0.00 | -$118.46M | -$106.15M | -3.05 |